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Background: Clostridium pasteurianum is one of the most promising biofuel producers within the genus
Clostridium owing to its unique metabolic ability to ferment glycerol into butanol. Although an efficient means is
available for introducing foreign DNA to C. pasteurianum, major genetic tools, such as gene knockout, knockdown,
or genome editing, are lacking, preventing metabolic engineering of C. pasteurianum.
Results: Here we present a methodology for performing chromosomal gene disruption in C. pasteurianum using
the programmable lactococcus Ll.ltrB group II intron. Gene disruption was initially found to be impeded by
inefficient electrotransformation of Escherichia coli-C. pasteurianum shuttle vectors, presumably due to host
restriction. By assessing the ability of various vector deletion derivatives to electrotransform C. pasteurianum and
probing the microorganism’s methylome using next-generation sequence data, we identified a new C. pasteurianum
Type I restriction-methylation system, CpaAII, with a predicted recognition sequence of 5′-AAGNNNNNCTCC-3′
(N = A, C, G, or T). Following rescue of high-level electrotransformation via mutation of the sole CpaAII site within the
shuttle vectors, we retargeted the intron to the cpaAIR gene encoding the CpaAI Type II restriction endonuclease
(recognition site of 5′-CGCG-3′). Intron insertion was potentially hindered by low retrohoming efficiency, yet this
limitation could be overcome by a procedure for enrichment of the intron insertion. The resulting ΔcpaAIR mutant
strain was efficiently electrotransformed with M.FnuDII-unmethylated plasmid DNA.
Conclusions: The markerless and plasmidless ΔcpaAIR mutant strain of C. pasteurianum developed in this study can
serve as a general host strain for future genetic and metabolic manipulation. Further, the associated gene disruption
protocol should not only serve as a guide for chromosomal gene inactivation studies involving mobile group II introns,
but also prove invaluable for applying metabolic engineering strategies to C. pasteurianum.
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Environmental and economic concerns surrounding the
consumption of finite petroleum-based resources have
led to the initiation of a rival biofuel industry, wherein
cleaner and renewable sources of fuel are produced using
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stock cost and availability [2]. Traditional feedstocks, such
as corn and molasses, are readily fermentable, yet fluctuate
drastically in price and compete with food supplies,
rendering them unsustainable for biofuel production [3].
Cellulosic biomass, on the other hand, is abundant and
economical, yet suffers from several bioprocessing draw-
backs, including a requirement for costly enzymatic hy-
drolysis and tedious chemical pretreatment of raw
substrates [4]. To be competitive with petrochemical pro-
cesses, feedstocks for biofuel production must be cheapd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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into value-added products. Crude glycerol, resulting from
the production of biodiesel at a concentration of 1 kg of gly-
cerol per 10 kg of biodiesel, is one of the few substrates
satisfying these criteria [5-8]. Owing to the immense expan-
sion of global biodiesel industries in recent years, crude gly-
cerol has become a desirable and economical feedstock.
However, microorganisms that can effectively dissimilate
and ferment glycerol remain predominantly untapped.
Clostridium pasteurianum is a mesophilic, strictly anaer-
obic, Gram-positive bacterium that possesses the metabolic
capacity to ferment glycerol as a sole source of carbon and
energy, yielding a mixture of gases (hydrogen and carbon
dioxide), acids (acetic and butyric), and alcohols (ethanol,
butanol, and 1,3-propanediol) [9,10]. Of these products, bu-
tanol is a promising biofuel due to its resemblance to trad-
itional gasoline with respect to physicochemical and fuel
combustion properties. Although several microorganisms
can metabolize glycerol, C. pasteurianum is the only species
that converts glycerol to butanol, producing up to 17 g l−1
butanol [9], with a maximum yield of 0.36 g g−1 crude gly-
cerol [11]. Biodiesel-derived glycerol requires only minor
pretreatment to remove impurities [12] and allows fermen-
tation performance comparable to that of refined glycerol
[11,12]. The ability of C. pasteurianum to metabolize
biodiesel-derived glycerol and its highly active butanol
biosynthetic pathway make C. pasteurianum a bacte-
rium of substantial biotechnological importance.
Several recent strategies have been employed in an at-
tempt to alter the central metabolism of C. pasteuria-
num to enhance its productivity. Unfortunately, a lack of
genetic tools has impeded metabolic engineering of C.
pasteurianum, allowing only random chemical mutagen-
esis techniques [13,14]. It is clear that metabolic engi-
neering will play a central role in the development of C.
pasteurianum as an efficient industrial producer. To this
end, an electroporation-mediated method of transformation
was recently established [15], allowing gene transfer to C.
pasteurianum with efficiencies of up to 104 transformants
μg−1 plasmid DNA. Such efficient plasmid transfer paves
the way to rational metabolic engineering strategies, includ-
ing gene disruption, knockdown, and overexpression tech-
niques [16,17], none of which have been explored using C.
pasteurianum. Gene disruption offers the most robust av-
enue for altering the expression of a native chromosomal
gene or metabolic pathway. In Clostridium, the preferred
tool for gene disruption is the ClosTron system, which has
been adapted from TargeTron™ technology in Escherichia
coli and exploits the retrohoming mechanism of bacterial
group II introns [18-20]. Owing to the broad host range of
group II introns, ClosTron-mediated gene disruptions have
been performed in at least 11 species of Clostridium
[18-25], leading to extensive metabolic engineering of
solvent-producing clostridia [20,23,24].Following our initial report of gene transfer to C.
pasteurianum, we have observed that electrotransfor-
mation efficiency varies drastically between certain shuttle
vectors [15]. Poor electrotransformation outcome was
shown to be specific to vectors harboring lactococcal
group II intron machinery. Restriction-modification
(RM) systems are the most common cause of trans-
formation recalcitrance in bacteria and potently in-
hibit plasmid transfer [17,26]. C. pasteurianum ATCC
6013 produces at least two active RM systems, CpaI
(5′-GATC-3′) [27] and CpaAI (5′-CGCG-3′) [28],
whereby restriction can be blocked using Dam (CpaI)
and M.FnuDII (CpaAI) methylation, respectively [15].
Based on our preliminary observation, it is possible
that C. pasteurianum expresses a third RM system
that recognizes a specific nucleotide sequence within
the clostridial gene disruption vectors. In this report,
we show that group-II-intron-mediated chromosomal
gene disruption in C. pasteurianum can be hindered
by host restriction and low retrohoming efficiency.
We demonstrate that overcoming these barriers leads
to successful derivation of the first gene disruption
mutant of C. pasteurianum. The developed system
for chromosomal gene disruption will promote future
metabolic engineering of C. pasteurianum.
Results
Shuttle vectors harboring Ll.ltrB intron machinery hinder
electrotransformation of Clostridium pasteurianum
To attempt chromosomal gene disruption in C. pasteuria-
num, we first electrotransformed plasmid pSY6catP, which
was developed for use in Clostridium acetobutylicum
[15,20]. This vector harbors the Ll.ltrB intron and its cog-
nate intron-encoded protein (IEP) gene, ltrA, both of
which are transcribed from the same C. acetobutylicum
ptb promoter within a pIMP1 vector backbone. Electro-
transformation efficiencies of 3.7 × 104 and 3.7 × 100 trans-
formants μg−1 plasmid DNA were obtained for pIMP1
and pSY6catP, respectively, indicating an inability of pSY6-
catP to transform C. pasteurianum (Figure 1). As the only
difference between pIMP1 and pSY6catP is the presence
of the intron machinery, we also attempted to transfer the
ClosTron plasmid pMTL007C-E2, which expresses the
same intron elements within a different, pMTL007-based
vector backbone. Like pSY6catP, pMTL007C-E2 also
yielded a poor electrotransformation efficiency of only
1.9 × 101 transformants μg−1 plasmid DNA (Figure 1).
Since pMTL007C-E2 possesses a different replication origin
from pSY6catP (repH and repL, respectively), we constructed
a repL derivative of pMTL007C-E2, named pMTL007C-E6,
in order to allow direct comparison of the two repL-based
intron-containing vectors, pMTL007C-E6 and pSY6catP.
Like pMTL007C-E2 and pSY6catP, pMTL007C-E6 suf-
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Figure 1 Electrotransformation data demonstrating that Clostridium pasteurianum restricts a 932 bp SacII-BstAPI fragment within the
ltrA gene of pSY6catP. Only relevant vector regions corresponding to the intron components are shown and are depicted to scale. To allow
alignment between constructs, deleted regions of vectors are represented as horizontal dashed lines and the ermB retrotransposition-activated
marker (RAM; unshaded box) within plasmids pMTL007C-E2 and pMTL007C-E6 is shown above the Ll.ltrB intron. Shaded box: Ll.ltrB intron; unshaded
box: ermB RAM; shaded arrow: ltrA; dashed line: Dcm recognition site; Pptb: ptb promoter (Clostridium acetobutylicum); Pfdx: fdx promoter (Clostridium
sporogenes); ND: not detected. For vector pMB, the truncated ltrA gene is depicted as a box, rather than an arrow. Relevant restriction endonuclease
recognition sites corresponding to BstAPI (B), MfeI (M), NheI (N), and SacII (S) are abbreviated using a single letter.
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DNA, whereas the control vector, pMTL85141, gave
1.5 × 104 transformants μg−1 plasmid DNA (Figure 1).
Taken together, these outcomes demonstrate that shut-
tle vectors carrying the Ll.ltrB intron machinery are in-
hibitory to electrotransformation of C. pasteurianum,
regardless of the vector backbone and replication origin
employed.
Inability to electrotransform Ll.ltrB-containing vectors is
due to the presence of the ltrA gene
Since the Ll.ltrB intron and its cognate IEP gene, ltrA,
are expressed from the same ptb promoter, we aimed toexpress the intron components independently in order
to determine which element is responsible for electro-
transformation inhibition. We constructed plasmids
pLtrB and pLtrA, which individually express the intron
and ltrA gene, respectively, with the use of the constitu-
tive C. acetobutylicum ptb promoter. Upon transfer to
C. pasteurianum, pLtrA hindered electrotransformation,
giving an efficiency of 1.4 × 101 transformants μg−1 plas-
mid DNA, whereas pLtrB generated 4.6 × 103 transfor-
mants μg−1 plasmid DNA (Figure 1), indicating that
electrotransformation inhibition is specific to the ltrA
region of pSY6catP. Since plasmid pLtrA expresses a
functional LtrA IEP product possessing maturase,
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low electrotransformation efficiency could be the result
of toxicity [30]. To test this hypothesis, we constructed
pDelPptb, in which the −35 and −10 signals of the ptb
promoter within pSY6catP were deleted. The resulting
plasmid should not produce intron RNA or a protein
product corresponding to the IEP. Despite deletion of
the promoter, pDelPptb failed to improve electrotrans-
formation efficiency and generated only 2.1 × 101 trans-
formants μg−1 plasmid DNA (Figure 1), implying that
low electrotransformation efficiency was not associated
with toxicity of the intron and IEP.
In light of these results, we speculated that a specific nu-
cleotide sequence within the ltrA gene could be targeted
by an uncharacterized RM system in C. pasteurianum.
Plasmid pLtrA contains two E. coli Dcm (5′-CCWGG-3′;
W =A or T) restriction recognition sites immediately
downstream of the ltrA coding sequence, which are not
found in the control vector, pIMP1. Since E. coli-C.
pasteurianum shuttle vector preparations destined for C.
pasteurianum electrotransformation are first methylated
in a Dcm+ E. coli host strain (ER1821), all such plasmids
would be methylated at both Dcm recognition sites (5′-
CmCWGG-3′). Certain methylated Dcm sites have
been shown to potently inhibit electrotransformation of
Clostridium thermocellum [31] and Clostridium ljung-
dahlii [32]. Therefore, we examined if Dcm methylation
contained within the ltrA gene region was responsible
for the decline in electrotransformation efficiency by con-
structing plasmid pDel2dcm, in which both Dcm recogni-
tion sites were mutated. Plasmid pDel2dcm failed to
generate any detectable transformants (Figure 1), indica-
ting that Dcm methylation is not responsible for the
reduced electrotransformation efficiency of pSY6catP.
Clostridium pasteurianum restricts a 334 bp region of the
ltrA gene region and restriction can be overcome by
extensive codon modification
In a first attempt to identify any unknown restriction rec-
ognition sequences within plasmid pLtrA, three constructs
were prepared by replacing various-sized restriction frag-
ments in the ltrA gene and its downstream region with a
48 bp stuffer fragment. The sizes of these restriction frag-
ments were 1,661 bp (pMB), 1,434 bp (pNS), and 688 bp
(pNM) (Figure 1). Upon electrotransformation of the three
resulting vectors, only pMB gave an improved electro-
transformation efficiency (8.8 × 103 transformants μg−1
plasmid DNA), whereas pNS and pNM yielded efficiencies
of 2.8 × 101 and 4.2 × 101 transformants μg−1 plasmid
DNA, respectively (Figure 1). This result indicates that the
putative restriction endonuclease recognition sequence is
contained within a 932 bp SacII-BstAPI restriction frag-
ment of pSY6catP (corresponding to 493 bp of the ltrA
coding region and 439 bp downstream of the ltrA gene).To reduce the size of the putative vector region
responsible for electrotransformation inhibition, we con-
structed another three vectors in which a 1,332 bp BglII-
EcoO109I restriction fragment was replaced with one of
the three different regions in the 932 bp SacII-BstAPI re-
striction fragment. Of the initial 932 bp region, plasmids
pFrag1, pFrag2, and pFrag3 possess fragments of sizes
339 bp, 338 bp, and 305 bp, respectively (Figure 2). Ap-
proximately 20 to 30 bp overlap was contained between
PCR fragments to ensure the unknown restriction recog-
nition site would be represented in its entirety. Of these
three constructs, only pFrag1 showed a significant re-
duction in electotransformation efficiency (7.1 × 101
transformants μg−1 plasmid DNA) compared to the con-
trol vector (pIMP1; 3.7 × 104 transformants μg−1 plasmid
DNA), whereas pFrag2 and pFrag3 yielded efficiencies of
3.5 × 104 and 9.7 × 103 transformants μg−1 plasmid
DNA, respectively (Figure 2). This result reduced the in-
hibitory region of pSY6catP from 932 bp to 339 bp. To
further verify that the 339 bp region of the ltrA coding
sequence is responsible for inhibition of electrotransfor-
mation of C. pasteurianum, we aimed to insert the detri-
mental sequence into a control vector that is able to
electrotransform C. pasteurianum at a high efficiency.
Thus, we constructed plasmid pSY334 by subcloning
334 bp of the 339 bp inhibitory fragment from pSY6catP
into pMTL85141 using SacII and AatII restriction sites.
Plasmid pMTL85141 consistently electrotransforms C.
pasteurianum with efficiencies on the order of 103to 104
transformants μg−1 plasmid DNA. As expected, pSY334
failed to generate any transformants upon several elec-
trotransformation attempts (Figure 2), suggesting potent
activity of the uncharacterized RM system in C.
pasteurianum.
To overcome the uncharacterized restriction barrier,
we attempted to mutate the unknown restriction recog-
nition sequence in the 334 bp inhibitory region of pSY6-
catP. Since this region is contained within the ltrA gene
sequence, our efforts were limited to silent mutations,
which would conserve the amino acid sequence and
yield a functional ltrA gene product. Consequently, we
silently mutated 98 bp spanning 83 codons within the
334 bp ltrA coding sequence, generating plasmid
pMut98, with the greatest number of consecutive nucle-
otides left unaltered following mutagenesis being 5 bp.
Since most RM recognition sequences are greater than
or equal to 6 bp, we envisioned that the unknown re-
striction recognition site would be mutated within
pMut98. As expected, pMut98 electrotransformed C.
pasteurianum with an efficiency of 3.2 × 103 transfor-
mants μg−1 plasmid DNA, an increase of approximately
three orders of magnitude compared to unmodified
pSY6catP (Figure 2). We then subcloned the mutated
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Figure 2 Electrotransformation data demonstrating that Clostridium pasteurianum restricts a 334 bp region within the ltrA gene
sequence of pSY6catP. The 932 bp SacII-BstAPI region of pSY6catP (see Figure 1) is enlarged to better show relevant vector components. Point
mutations within the ltrA coding sequence are depicted as vertical bands. Enlarged vector components are depicted to scale. Shaded box: Ll.ltrB
intron; shaded arrow: ltrA; dashed line: Dcm recognition site; Pptb: ptb promoter (C. acetobutylicum); ND: not detected. Relevant restriction endonuclease
recognition sites corresponding to AatII (A), BglII (B), EcoO109I (E), and SacII (S) are abbreviated using a single letter.
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E6, respectively. Similar to pMut98, codon modification
led to significantly increased electrotransformation
efficiencies for both pMTLCP-E2 (1.9 × 103 transfor-
mants μg−1 plasmid DNA) and pMTLCP-E6 (2.7 × 103
transformants μg−1 plasmid DNA), compared to 1.9 × 101
transformants μg−1 plasmid DNA for pMTL007C-E2
and 3.2 × 100 transformants μg−1 plasmid DNA for
pMTL007C-E6 (Figure 1).
Methylome analysis unveils a unique restriction-
modification system in Clostridium pasteurianum (CpaAII)
that restricts a single 5′-AAGNNNNNCTCC-3′ site within
pSY6catP
Using single molecule real-time (SMRT) sequencing
data, it is possible to probe an organism’s unique DNA
methylation profile (methylome). To determine a puta-
tive recognition sequence of the uncharacterized RMsystem, we utilized existing C. pasteurianum SMRT gen-
ome sequencing data generated using the RS II analyzer
[33]. Due to current technical restraints in SMRT
methylome analysis, only m6A residues could be de-
tected, as identification of m5C residues requires more
extensive sequence coverage. Surprisingly, methylome
analysis revealed a previously unidentified methylation
motif possessing a putative recognition sequence of 5′-
AAGNNNNNCTCC-3′, which we have designated
CpaAII. A single CpaAII recognition site exists within
the 334 bp of the ltrA gene shown to inhibit electro-
transformation of C. pasteurianum. To further verify
the CpaAII recognition sequence, we constructed plas-
mid pDelCpaAII, in which the unique CpaAII recogni-
tion site was mutated by introducing only three silent
point mutations within the coding sequence of ltrA.
Similar to pMut98, with 98 silent mutations and a high
electrotransformation efficiency of 3.2 × 103 transformants
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crease in electrotransformation efficiency (1.6 × 103 trans-
formants μg−1 plasmid DNA) compared to unmodified
pSY6catP (3.7 × 100 transformants μg−1 plasmid DNA).
Conversely, we aimed to create a unique CpaAII recog-
nition site by introducing only two point mutations within
pMTL85141, which does not contain any CpaAII re-
cognition sites and electrotransforms C. pasteurianum
efficiently. The resulting plasmid, pCpaAII, failed to
electrotransform C. pasteurianum, further verifying the
existence of the new RM system.
We analyzed all other E. coli-C. pasteurianum shuttle
vectors utilized in this work and only pMTL007C-E2
and pMTL007C-E6, both harboring the lactococcal
group II intron machinery, were found to possess a
CpaAII site. The CpaAII site within these vectors is
identical to that in pSY6catP, as both are located within
the ltrA gene. Unexpectedly, both pMTL007C-E2 and
pMTL007C-E6 were found to possess an additional CpaAII
site, which was reconfirmed by Sanger sequencing, within
the erythromycin (ermB) retrotransposition-activated-
marker (RAM) region. To assess the effect of the add-
itional CpaAII site on electrotransformation, we used
plasmids pMTLCP-E2 and pMTLCP-E6, in which the
detrimental CpaAII site within the ltrA coding sequence
is mutated yet the additional site within the ermB RAM is
left unaltered, to electrotransform C. pasteurianum. As re-
ported above, pMTLCP-E2 and pMTLCP-E6 generated
relatively high electrotransformation efficiencies of 1.9 × 103
transformants μg−1 plasmid DNA and 2.7 × 103 trans-
formants μg−1 plasmid DNA, respectively, suggesting that
the additional CpaAII site is not subject to restriction by
C. pasteurianum.
Generation of an intron-mediated gene disruption mutant
of Clostridium pasteurianum
Since plasmid pMut98 afforded a substantial improvement
in electrotransformation efficiency compared to pSY6catP,
we used it as a C. pasteurianum gene disruption vector. In
addition, we replaced the C. acetobutylicum ptb promoter
controlling intron transcription with the promoter from
the C. pasteurianum thiolase gene. The resulting vector,
pSYCP, was then used to target nucleotide position 176
within the antisense strand (176a) of the putative cpaAIR
gene (corresponding to locus tag CP6013_2592), which
was identified within the draft genome sequence of C. pas-
teurianum ATCC 6013 [GenBank accession number
JPGY01000000] [33] and encodes the CpaAI Type II re-
striction endonuclease. Consistent with restriction ana-
lyses [15,28], The Restriction Enzyme Database (REBASE)
[34] predicts a recognition sequence of 5′-CGCG-3′ for
the putative cpaAIR gene product. We selected the cpaAIR
gene for gene disruption since the predicted 176a insertion
site generated a high predicted insertional score (7.3), genedisruption is unlikely lethal, and the resulting mutant
should prove useful for future genetic and metabolic en-
gineering applications by abolishing the requirement for
methylation of plasmid DNA prior to electrotransforma-
tion [22,35]. The retargeted pSYCP-cpaAIR plasmid was
electroporated to C. pasteurianum and transformants
were selected using thiamphenicol. Transformant colonies
were first screened for insertion of the intron within the
cpaAIR coding sequence, resulting in an insertion of
915 bp, using two gene-specific primers flanking the pre-
dicted 176a intron insertion site (Figure 3A). Of 28
screened colonies, all possessed the wild-type PCR product
without the intron insertion. However, both gene-intron
junctions could be detected in several pSYCP-cpaAIR
transformant colonies using one gene-specific and one
intron-specific primer (data not shown), signifying success-
ful intron insertion had occurred. The resulting mosaic
colonies were presumed to be comprised of a mixture of
wild-type and intron-disrupted mutant cells, potentially due
to low retrohoming efficiency (J. Perutka, personal commu-
nication). To enrich and isolate the mutant cells, mosaic
colonies were subcultured in liquid 2 × YTG medium con-
taining thiamphenicol every 12 hours for a total of 5 days,
or 10 transfers, followed by rescreening of the resulting col-
onies for the intron insertion using two gene-specific
primers. Of seven colonies screened, four possessed the de-
sired intron insertion (Figure 3B). Finally, one such positive
colony was selected and used for additional PCR verifica-
tion by amplifying both gene-intron junctions to ensure
proper intron insertion and orientation (Figure 3C).
In another attempt for gene disruption, we constructed
plasmids pMTLCP-E2-cpaAIR and pMTLCP-E6-cpaAIR,
which possess an erythromycin RAM allowing direct selec-
tion of cells containing an intron insertion. Thiamphenicol-
resistant transformants harboring pMTLCP-E2-cpaAIR or
pMTLCP-E6-cpaAIR were restreaked onto erythromycin-
containing 2 × YTG agar plates to select for intron disrup-
tion mutants. Upon restreaking 24 transformant colonies,
no erythromycin-resistant colonies were able to grow,
signifying unsuccessful insertion of the RAM-containing
intron into the cpaAIR gene of C. pasteurianum. There-
fore, we recommend plasmid pSYCP, containing a marker-
less Ll.ltrB intron, with our developed enrichment method
for performing chromosomal gene disruptions in C.
pasteurianum.
Curing of intron donor plasmid pSYCP-cpaAIR
Prior to phenotypic characterization of the resulting
ΔcpaAIR mutant, we attempted to cure the pSYCP-
cpaAIR intron donor plasmid. Based on previous reports
involving plasmid curing in Clostridium, we employed a
method based on repeated subculturing in non-selective
growth medium [22,23]. A single ΔcpaAIR mutant col-
ony was grown in liquid 2 × YTG medium and the seed
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Figure 3 Identification and verification of ΔcpaAIR mutant colonies of Clostridium pasteurianum. A) Schematic diagram depicting primer
annealing sites and expected PCR products of wild-type cells (left) and ΔcpaAIR mutant cells (right). Insertion of the Ll.ltrB intron into the cpaAIR gene
leads to a 915 bp increase in size of the full-length PCR product generated using primers flanking the 176a intron insertion site (REN.Rv + REN.Fw).
Both 5′ and 3′ gene-intron junction PCR products can be detected in ΔcpaAIR mutant cells using primer sets REN.Rv + ltrB.Rv and ltrB.Fw + REN.Fw,
respectively. B) Colony PCR screening of gene disruption enrichment colonies for presence of intron insertion by amplification of the full-length
product. Lane 1: marker; lane 2: no template control; lane 3: wild-type, non-recombinant C. pasteurianum colony; lanes 4 to 10: gene disruption
enrichment colonies; lanes 4, 5, 7, and 8: positive colonies; lanes 6, 9, and 10: negative colonies. C) Further genomic verification of a single positive
ΔcpaAIR mutant colony by amplification of all three PCR products depicted in Figure 3A (5′ junction, 3′ junction, and full product). A wild-type
C. pasteurianum colony was included as a control for all three PCR primer sets. Lane 1: marker; lanes 2 to 4: wild-type colony; lanes 5 to 7: ΔcpaAIR
mutant colony; lanes 2 and 5: 5′ junction; lanes 3 and 6: 3′ junction; lanes 4 and 7: full product.
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every 12 hours for a total of three or seven successive
transfers. The resulting cells were serially diluted and
plated onto non-selective 2 × YTG agar. A total of 36
colonies from the three-transfer and seven-transfer
methods were picked and restreaked onto both non-
selective and thiamphenicol-containing 2 × YTG agar
plates. A total of 18 and 33 thiamphenicol-sensitive col-
onies, corresponding to curing efficiencies of 50% and
92%, were identified in the three- and seven-transfer ap-
proaches, respectively. A total of four thiamphenicol-
sensitive colonies were subjected to further confirmation
of plasmid curing based on their sensitivity to thiampheni-
col and their inability to generate a plasmid-borne PCR
product upon conducting colony PCR using primers
frag3.BglII.S + frag3.EcoO109I.AS (data not shown).Characterization of the Clostridium pasteurianum ΔcpaAIR
gene disruption mutant
The resulting ΔcpaAIR gene disruption mutant should
not produce a functional CpaAI Type II restriction
endonuclease and, therefore, should be efficiently
transformed with plasmid DNA lacking methylation by
the FnuDIIM methyltransferase (5′-m5CGCG-3′) [15]. To
test this phenotype, we used the plasmid-cured ΔcpaAIR
mutant strain to assess its capacity to be electrotransformed
with both M.FnuDII-unmethylated and M.FnuDII-methyl-
ated plasmid substrates (Figure 4). We first verified that M.
FnuDII unmethylated plasmid pMTL85141ermB, a dual
erythromycin- and thiamphenicol-selectable derivative of
pMTL85141 [15], fails to electrotransform wild-type C. pas-
teurianum (Figure 4, top left panel) due to CpaAI




Figure 4 Electrotransformation results demonstrating successful electrotransformation of ΔcpaAIR gene disruption cells with
M.FnuDII-unmethylated plasmid pMTL85141ermB. Wild-type cells (top row) and ΔcpaAIR gene disruption cells (bottom row) of Clostridium
pasteurianum were electroporated separately with M.FnuDII-unmethylated (left column) and M.FnuDII-methylated (right column) plasmid
pMTL85141ermB. M.FnuDII methylation was achieved in vivo using an Escherichia coli strain harboring pMTL85141ermB and pFnuDIIMKn. Varying
volumes of electrotransformation outgrowth cell suspensions were plated to give approximately equal numbers of transformants between
electrotransformations. Hence, the number of transformant colonies shown does not allow for a direct comparison of electrotransformation efficiency.
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electrotransformation efficiency of 1.1 × 104 transformants
μg−1 plasmid DNA). We next attempted to electrotransform
M.FnuDII-unmethylated plasmid pMTL85141ermB to
ΔcpaAIR mutant cells and, as expected, pMTL85141ermB
(Figure 4, bottom left panel; electrotransformation efficiency
of 9.6 × 102 transformants μg−1 plasmid DNA) electro-
transformed at a level comparable to M.FnuDII-
methylated pMTL85141ermB (Figure 4, bottom right
panel; electrotransformation efficiency of 2.3 × 103
transformants μg−1 plasmid DNA). Successful electro-
transformation of methylation-deficient plasmid DNA
indicates inactivation of the cpaAIR Type II endo-
nuclease in the ΔcpaAIR mutant strain. Note that
electrotransformation efficiency of ΔcpaAIR cells was
more than an order of magnitude lower than wild-type
C. pasteurianum, which we have observed in two in-
dependent electrotransformation experiments. We are
uncertain of the reason for the reduced electrotrans-
formation efficiency of the ΔcpaAIR mutant. However,
electrotransformation efficiency of the ΔcpaAIR mu-
tant strain is still comparable to many other clostridial
procedures [36-39], generating 102 to 103 transfor-
mants μg−1 plasmid DNA.Discussion
Genetic manipulation techniques, particularly chromo-
somal gene disruption, have found widespread use in
the solventogenic clostridia, permitting rational meta-
bolic engineering approaches and the generation of
mutant strains with enhanced metabolic capabilities
[17]. While C. pasteurianum has recently been identi-
fied as a promising industrial producer due to its
unique metabolic capabilities, it has suffered from a
lack of available genetic tools for extensive strain im-
provement. Here, we further apply our recent DNA
electrotransformation protocol to conduct chromo-
somal gene disruption in C. pasteurianum with con-
current identification and characterization of a new
C. pasteurianum RM system. This biotechnological
development is expected to pave the way towards gen-
etic and metabolic engineering of this microorganism
for a wider range of industrial applications. Technic-
ally, we show that the ability to perform group-
II-intron-mediated chromosomal gene disruptions in
C. pasteurianum is limited by host restriction and
low-level intron retrohoming efficiency, and overcom-
ing these obstacles leads to successful derivation of
C. pasteurianum mutant strains.
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derivatives of pSY6catP (Figures 1 and 2) and probing the
methylome of C. pasteurianum using SMRT genome se-
quencing data, we have concluded that the inability of
intron-containing vectors for chromosomal gene disrup-
tion to efficiently electrotransform C. pasteurianum is due
to restriction by a new RM system, designated as CpaAII.
Based on methylation motifs predicted from methylome
analysis, we propose a recognition sequence of 5′-
AAGNNNNNCTCC-3′ for the CpaAII RM system. The
proposed CpaAII recognition sequence is indicative of
Type I RM systems, which are widespread in bacteria and
recognize nucleotide sequences comprised of 4 to 8 de-
generate (N) residues flanked by short (2 to 5 bp) defined
sequences [34]. Further, all Type I RM systems character-
ized to date encode m6A-specific methyltransferases [40],
as we have proposed for CpaAII. Finally, a single Type I
RM system is annotated in the draft genome sequence of
C. pasteurianum ATCC 6013 [33] and encodes the three
host specificity domains, corresponding to restriction
(hsdR; locus tag CP6013_1662), modification (hsdM; locus
tag CP6013_1663), and specificity (hsdS; locus tag
CP6013_1664), that are typical characteristics of Type I
RM systems [40].
All vector derivatives with a significantly reduced abil-
ity to electrotransform C. pasteurianum in this study
were found to possess at least one CpaAII recognition
sequence. In the case of pSY6catP, mutation of the single
CpaAII recognition site within the ltrA gene sequence
restored electrotransformation to a level comparable to
control vectors lacking lactococcal group II intron ele-
ments. Conversely, only one of the two CpaAII restric-
tion recognition sequences within ClosTron plasmids
pMTL007C-E2 and pMTL007C-E6 was found to nega-
tively affect electrotransformation efficiency of C. pas-
teurianum. A possible explanation for this outcome is
that the actual CpaAII recognition sequence may differ
slightly from the proposed motif predicted by methy-
lome analysis in this study. It is likely that the actual
CpaAII recognition sequence is more stringent than the
predicted 5′-AAGNNNNNCTCC-3′ motif, as only one of
the two CpaAII recognition sequences within pMTL007C-
E2 and pMTL007C-E6 was subject to restriction. For ex-
ample, the recognition sequence of the Type I RM system
from C. perfringens ATCC 13124, 5′-CACNNNNNR-
TAAA-3′ (R =A or G), is similar in structure to that of the
predicted CpaAII enzyme (5′-AAGNNNNNCTCC-3′), yet
contains a partially-degenerate 5 bp element at the 3′ end,
rather than a defined 4 bp element in the case of CpaAII.
Increasing the coverage of SMRT sequencing data (our on-
going approach) could potentially resolve this apparent
discrepancy.
Having overcome host restriction of shuttle vectors
harboring the lactococcal ltrA gene, we used pMut98,which contains no CpaAII recognition sites, as the basis
for deriving our chromosomal gene disruption vector.
However, retrohoming efficiency of the intron proved to
be too low to isolate a homogeneous gene disruption mu-
tant directly from pSYCP-cpaAIR transformant colonies,
as most colonies were found to represent a heterogeneous
mixture of wild-type and mutant cells. Mixed-genotype
transformant colonies have been described in other intron-
based gene disruption studies [24]. This outcome is not
specific to the cpaAIR(176a) insertion site employed in this
study, as we have observed mixed-genotype colonies using
predicted target sites of three other chromosomal genes in
C. pasteurianum (data not shown). As such, retrohoming
efficiency of the Ll.ltrB intron appears to be lower in C.
pasteurianum compared to other solventogenic clostridia
[18-20], as gene disruption mutants are typically identified
and isolated following transfer of the intron donor plas-
mid. The use of a selectable RAM inserted into domain
IV of the intron [18,19] within vectors pMTL007C-E2/
pMTLCP-E2 and pMTL007C-E6/pMTLCP-E6 was not
able to enhance selection and isolation of true intron
disruption colonies, presumably due to a further de-
crease in retrohoming efficiency resulting from the
presence of cargo DNA within the intron sequence [18].
Thus, to isolate a homogeneous gene disruption colony,
we employed an enrichment procedure by subculturing a
heterogeneous transformant colony in selective liquid
medium to promote intron insertion. Following our en-
richment protocol, approximately half of the screened col-
onies possessed the desired intron insertion (Figure 3),
suggesting its effectiveness in increasing retrohoming effi-
ciency of the Ll.ltrB intron in C. pasteurianum.
Plasmid curing has proven to be an essential and often
laborious aspect of clostridial strain engineering efforts.
Several clostridial host-vector systems have been shown to
produce plasmids that exhibit strong segregational stability
in the absence of selection. This has led to the develop-
ment of strategies involving induction of plasmid instabil-
ity through the use of negative-selectable markers (such as
pyrF [41]) and antisense RNA targeted to the plasmid rep-
lication protein [42]. We have shown that efficient plasmid
curing in C. pasteurianum does not require artificial in-
duction methods, as plasmids based on the common repL
replication origin can be efficiently cured by subculturing
cells in non-selective growth medium for a total of only
three successive transfers (approximately two days). This
outcome contrasts other reported clostridial plasmid cur-
ing procedures, which often require up to seven successive
transfers to cure replicative intron donor plasmids [22,25].
The ΔcpaAIRmutant strain developed in this study does
not harbor plasmids nor antibiotic resistance markers, as
it was constructed without the use of a RAM-containing
intron, and should prove advantageous for future genetic
and metabolic engineering efforts by abolishing the
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prior to electrotransformation. Note that shuttle vectors
transforming ΔcpaAIR mutant cells still require CpaI
methylation, which can be readily performed using Dam+
E. coli strains for plasmid propagation. Analogous
restriction-negative mutants have also been produced in
C. acetobutylicum [35] and Clostridium cellulolyticum
[22] through disruption of the genes encoding the Cac824I
and CceI Type II RM systems, respectively. Our gene dis-
ruption system should prove to be broadly applicable to
any non-essential gene within the genome of C. pasteuria-
num, permitting that a viable intron insertion site can be
identified. Since metabolic engineering approaches often
involve disruption of multiple genes and metabolic path-
ways, strains with multiple markerless intron insertions
can be envisioned using our strategy by employing itera-
tive rounds of intron retargeting, electrotransformation,
enrichment, and plasmid curing. In fact, a recent report
has detailed intron-mediated disruption of up to five genes
in C. acetobutylicum [43]. Since the ΔcpaAIR mutant con-
structed in this report is the first C. pasteurianum mutant
strain obtained using group II intron technology, we rec-
ommend using the cpaAIR(176a) target site and plasmid
pSYCP-cpaAIR as a control for future intron-mediated
gene disruption studies. The cpaAIR(176a) insertion site
generated a predicted insertional score of 7.3 using a Ll.ltrB
insertion site prediction algorithm (TargeTronics, LLC,
Austin, Texas, United States) and, therefore, we recom-
mend selecting sites of equal or greater score for disruption
of genes in C. pasteurianum using the Ll.ltrB group II in-
tron. It is expected that the intron donor plasmid and asso-
ciated gene disruption methodologies detailed herein will
add to the expanding genetic toolkit available for C. pas-
teurianum and lead to rewarding metabolic engineering ef-
forts involving this important biotechnological bacterium.
Conclusions
In this work, we have developed and utilized a gene disrup-
tion plasmid (pSYCP) and intron enrichment strategy to
generate a mutant strain of C. pasteurianum deficient in
CpaAI restriction. The resulting ΔcpaAIR strain is devoid
of plasmids and antibiotic resistance markers, and does not
require M.FnuDII methylation of plasmid DNA substrates
to achieve efficient electrotransformation, making it an
ideal host background for metabolic engineering appli-
cations. This is the first report of gene disruption and
targeted genetic manipulation of C. pasteurianum and
represents an important divergence from previously
employed random chemical mutagenesis methods.
Methods
Bacterial strains, plasmids, and oligonucleotides
Bacterial strains and plasmids employed in this work are
listed in Table 1 and oligonucleotide sequences are givenin Table 2. E. coli DH5α was utilized for vector construc-
tion and cloning purposes and ER1821[pFnuDIIMKn] for
methylation of E. coli-C. pasteurianum shuttle vectors
destined for C. pasteurianum [15]. Vectors pIMP1 [44]
and pSY6 [20] were kindly provided by Professor Terry
Papoutsakis (University of Delaware, Newark, Delaware,
United States) and Professor Sheng Yang (Chinese Acad-
emy of Sciences, Shanghai, China). Plasmid pMTL85141
[45] and the ClosTron vector, pMTL007C-E2 [18], were
kindly shared by Professor Nigel Minton (University of
Nottingham, Nottingham, United Kingdom). Oligonucleo-
tides and gBlocks were synthesized by Integrated DNA
Technologies (IDT, Coralville, Iowa, United States). Oligo-
nucleotides were prepared at the 25 nm scale using stand-
ard desalting. Custom gene synthesis was performed by
Bio Basic Inc. (Markham, Ontario, Canada).
Growth and maintenance conditions
E. coli strains were cultivated aerobically at 37°C in lysog-
eny broth (LB) and recombinant derivatives were selected,
when necessary, with ampicillin (100 μg ml−1), chloram-
phenicol (30 μg ml−1), or kanamycin (30 μg ml−1) (Sigma-
Aldrich; St. Louis, Missouri, United States). Antibiotic
levels were reduced by half for selection of E. coli strains
harboring two vectors. C. pasteurianum strains were
grown anaerobically at 37°C in 2 × YTG medium (16 g l−1
tryptone, 10 g l−1 yeast extract, 5 g l−1 glucose, and 4 g l−1
sodium chloride, pH 6.3) (Sigma-Aldrich; St. Louis, Mis-
souri, United States) within an anaerobic containment
chamber (Plas-Labs; Lansing, Michigan) containing an at-
mosphere of 5% CO2, 10% H2, and 85% N2. Strict anaer-
obic conditions were maintained and monitored through
the use of a palladium catalyst fixed to the heater of the
chamber, removal of oxygen from growth medium via
autoclaving, and addition of resazurin (1 mg l−1) to all
solid and liquid media preparations. Recombinant C.
pasteurianum strains were selected, when necessary,
with 10 μg ml−1 thiamphenicol or 25 μg ml−1 erythro-
mycin. Recombinant E. coli and C. pasteurianum were
stored frozen in 15% glycerol at −80°C (both species) or
as sporulated colonies on solidified 2 × YTG agar plates
(C. pasteurianum).
DNA isolation, manipulation, and electrotransformation
Plasmid DNA was extracted from E. coli and purified
using an EZ-10 Spin Column Plasmid DNA Miniprep
Kit (Bio Basic, Inc.; Markham, Ontario, Canada). Intact,
high molecular weight C. pasteurianum genomic DNA
was extracted from a 60 ml culture (OD600 0.5-0.7) by
first washing cells in 40 ml of a buffer containing
25 mM potassium phosphate, pH 7.0, and 6 mM
MgSO4, followed by resuspension in 15 ml of the same
buffer supplemented with 50% sucrose and 200 μg/ml
lysozyme (Sigma-Aldrich; St. Louis, Missouri, United
Table 1 Strains and plasmids employed in this study
Strains or plasmids Relevant characteristics Source or reference
Strains













Disruption mutant generated by inserting the Ll.ltrB intron into position 176a of the cpaAIR gene
encoding the CpaAI RENase
This study
Plasmids
pFnuDIIMKn M.FnuDII methyltransferase plasmid for methylation of E. coli-C. pasteurianum shuttle vector s
(KmR ; p15A ori)
[15]
pIMP1 E. coli-Clostridium shuttle vector (ApR; ColE1 ori; EmR; repL ori) [44]
pMTL85141 E. coli-Clostridium shuttle vector (CmR/TmR; ColE1 ori; repL ori) [45]
pMTL85141ermB E. coli-Clostridium shuttle vector (CmR/TmR; EmR; ColE1 ori; repL ori) [15]
pSY6catP E. coli-Clostridium shuttle vector expressing the Ll.ltrB intron and ltrA IEP from the Clostridium
acetobutylicum ptb promoter (ApR ; CmR/TmR; ColE1 ori; repL ori)
[15]
pMTL007C-E2 ClosTron vector expressing the Ll.ltrB intron with RAM and ltrA IEP from the Clostridium sporogenes
fdx promoter (CmR/TmR; ColE1 ori; repH ori; EmR RAM)
[18]
pMTL007C-E6 repL derivative of pMTL007C-E2 This study
pltrB ltrA-deletion derivative of pSY6catP This study
pltrA Ll.ltrB-deletion derivative of pSY6catP This study
pDelPptb Derived by deleting the −35 and −10 signals of the C. acetobutylicum ptb promoter from plasmid
pSY6catP
This study
pDel2dcm Derived by mutating the two E. coli Dcm restriction recognition sites downstream of the ltrA
coding sequence within plasmid pSY6catP
This study
pMB Derived by replacing a 1,661 bp MfeI + BstAPI restriction fragment of pSY6catP with a 48 bp stuffer
fragment
This study
pNM Derived by replacing a 688 bp NheI + MfeI restriction fragment of pSY6catP with a 48 bp stuffer
fragment
This study
pNS Derived by replacing a 1,434 bp NheI + SacII restriction fragment of pSY6catP with a 48 bp stuffer
fragment
This study
pFrag1 Derived by replacing a 1,332 bp BglII + EcoO109I restriction fragment of pSY6catP with a 589 bp
ltrA region
This study
pFrag2 Derived by replacing a 1,332 bp BglII + EcoO109I restriction fragment of pSY6catP with a 363 bp
ltrA region
This study
pFrag3 Derived by replacing a 1,332 bp BglII + EcoO109I restriction fragment of pSY6catP with a 574 bp
ltrA region
This study
pSY334 Derived by subcloning a 334 bp SacII + AatII fragment of the ltrA coding sequence into plasmid
pMTL85141
This study
pMut98 pSY6catP derivative possessing 98 silent mutations in the ltrA coding sequence This study
pMTLCP-E2 Derived by subcloning a 1,427 bp MscI + AclI restriction fragment of pMut98 into plasmid
pMTL007C-E2
This study
pMTLCP-E6 Derived by subcloning a 1,427 bp MscI + AclI restriction fragment of pMut98 into plasmid
pMTL007C-E6
This study
pDelCpaAII Deletion of the unique CpaAII recognition site within pSY6catP by introducing three silent
point mutations
This study
pCpaAII Introduction of a unique CpaAII recognition site within pMTL85141 by introducing two
point mutations
This study
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Table 1 Strains and plasmids employed in this study (Continued)
pSYCP-cpaAIR Derived by replacing the ptb promoter of pMut98 with a thl promoter and targeting the Ll.ltrB
intron to position 176a of the cpaAIR gene
This study
pMTLCP-E2-cpaAIR Targeting construct of plasmid pMTLCP-E2 for disruption of the cpaAIR gene at position 176a This study
pMTLCP-E6-cpaAIR Targeting construct of plasmid pMTLCP-E6 for disruption of the cpaAIR gene at position 176a This study
ApR: ampicillin resistant; CmR: chloramphenicol resistant; EmR: erythromycin resistant; KmR: kanamycin resistant; TmR: thiamphenicol resistant.
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45 minutes, genomic DNA was extracted from 1.0 to
5.0 ml samples of protoplast suspension using a DNeasy
Blood and Tissue Kit from Qiagen (Valencia, California,
United States). Due to the high nuclease content of clos-
tridia, hypertonic sucrose (50% w/v) was added to buffer
































Italics: relevant restriction endonuclease recognition sequences.treated with 100 μg/ml RNase A prior to additional purifi-
cation using a Genomic DNA Clean & Concentrator kit
from Zymo Research (Irvine, California, United States).
DNA restriction fragments and PCR products were
purified directly or from agarose gels using an EZ-10 Spin
Column DNA Gel Kit (Bio Basic, Inc.; Markham, Ontario,
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Taq DNA Polymerase, Phusion High-Fidelity DNA Poly-
merase, and Quick Ligation Kit were purchased from New
England Biolabs (Whitby, Ontario, United States). All
commercial enzymes and kits were used according to the
manufacturer’s instructions. Electrotransformation of C.
pasteurianum was performed as previously described [15].
Vector construction
Plasmid pMTL007C-E6 was constructed from pMTL007C-
E2 by ligation of a 878 bp AscI + FseI digestion fragment of
pMTL85141 containing the repL replication module with a
7,300 bp product of pMTL007C-E2 resulting from diges-
tion with the same restriction enzymes.
pLtrB was constructed by digesting pSY6catP with NheI
+ BstAPI, extracting the resulting 6,131 bp fragment, and
ligating it with complementary oligos ltrB.NheI.S + ltrB.
BstAPI.AS that had been annealed to generate compatible
NheI and BstAPI restriction ends. Complementary oligo-
nucleotides were mixed in equimolar amounts, heated to
95°C in a water bath, and allowed to anneal by disconnect-
ing the power source from the water bath. For construc-
tion of pLtrA, the entire 3,426 bp Ll.ltrB-ltrA intron region
was removed from pSY6catP using XhoI + BstAPI diges-
tion and replaced with a 2,398 bp PCR product containing
only the ltrA coding sequence, generated using primers
ltrA.XhoI.S + ltrA.BstAPI.AS. The resulting product was
digested with XhoI + BstAPI and ligated with the 5,072 bp
pSY6catP vector backbone to place ltrA under transcrip-
tional control of the ptb promoter. Plasmid pDelPptb was
derived from pSY6catP by replacement of the 131 bp
SmaI + XhoI digestion product containing the C. aceto-
butylicum ptb promoter with a 56 bp stuffer fragment
lacking −35 and −10 promoter signals derived by anneal-
ing oligonucleotides del-Pptb.S + del-Pptb.AS. Ligation-
proficient SmaI and XhoI restriction ends were generated
upon successful annealing of complementary oligonucleo-
tides. pDel2dcm was derived from pSY6catP by replacing
a 924 bp SacII + BstAPI restriction fragment with the same
924 bp sequence in which the two Dcm sites were mutated
by two single-base-pair mutations. The Dcm deletion
fragment was synthesized by Bio Basic, Inc. (Markham,
Ontario, Canada), digested with SacII + BstAPI, and ligated
into the corresponding sites of pSY6catP. The three re-
striction fragment deletion constructs, pMB, pNM, and
pNS, were prepared by digesting pSY6catP with MfeI +
BstAPI, NheI +MfeI, and NheI + SacII, respectively, and
annealing the resulting vector backbones with the respect-
ive annealed oligonucleotide pairs, MfeI/BstAPI.S +MfeI/
BstAPI.AS (pMB), NheI/MfeI.S +NheI/MfeI.AS (pNM),
and NheI/SacII.S +NheI/SacII.AS (pNS).
To construct pFrag1, pFrag2, and pFrag3, a 1,332 bp
BglII + EcoO109I restriction fragment was removed from
pSY6catP and replaced with a 589 bp (primers frag1.BglII.S + frag1.EcoO109I.AS), 363 bp (primers frag2.
BglII.S + frag2.EcoO109I.AS), or 574 bp (primers frag3.
BglII.S + frag3.EcoO109I.AS) PCR product, respectively,
corresponding to various products of the ltrA coding
region of pSY6catP. To construct pSY334, a 334 bp
SacII + AatII fragment of the ltrA coding sequence was
subcloned into the corresponding sites of pMTL85141.
To mutate the unknown restriction recognition se-
quence within the inhibitory 334 bp region of the ltrA
coding sequence, a 655 bp gBlock was synthesized pos-
sessing 98 silent mutations in which 83 codons were al-
tered. A 731 bp PCR product containing the 3′ ltrA
coding sequence and downstream region, and possessing
25 bp overlap with the mutated gBlock, was amplified
using primers 3′SOE.S + SOE.EcoO109I.AS. The PCR
product was loaded on a 1.0% agarose gel (Bio Basic, Inc.;
Markham, Ontario, Canada), stabbed with a micropipette
tip, and used as template along with 5 ng of the purified
gBlock in a splicing by overlap extension (SOE) PCR by
cycling for 10 cycles prior to adding primers gBlock.BglII.
S + SOE.EcoO109I.AS and cycling for 25 additional cycles.
The resulting product was digested with BglII + EcoO109I
and ligated with pSY6catP that had been digested with the
same restriction endonucleases to generate pMut98. Plas-
mids pMTLCP-E2 and pMTLCP-E6 were constructed by
subcloning a 1,427 bp MscI + AclI restriction fragment of
pMut98 into the corresponding sites of pMTL007C-E2
and pMTL007C-E6, respectively.
To mutate the CpaAII recognition site of pSY6catP
using three silent point mutations, a gBlock was synthe-
sized in which codons 521 (AGU→UCU; Ser) and 523
(GCU→GCC; Ala) were mutated within the ltrA coding
sequence. In a manner similar to pMut98, the mutated
gBlock was fused with the same 731 bp 3′ ltrA product
using SOE PCR. The resulting product was digested with
BglII + EcoO109I and ligated with BglII- and EcoO109I-
digested pSY6catP to yield plasmid pDelCpaAII. Con-
versely, a unique CpaAII restriction recognition sequence
was generated within pMTL85141 by first annealing com-
plementary oligonucleotides CpaAII-anneal.S + CpaAII-
anneal.AS. The resulting annealed product, possessing
cohesive XbaI + HindIII ends, was ligated into the corre-
sponding sites of pMTL85141 to give plasmid pCpaAII.
Ll.ltrB intron design was performed using the computer
algorithm developed by TargeTronics, LLC (Austin, Texas,
United States). The insertion site with the highest pre-
dicted insertion score splicing into the antisense strand
was selected corresponding to nucleotide position 176
(score of 7.3) of the CpaAI restriction endonuclease gene,
cpaAIR. Plasmid pMut98 was used as the basis for a C.
pasteurianum TargeTron gene disruption vector. For
retargeting pMut98, a 572 bp gBlock fragment was synthe-
sized possessing mutations in the IBS, EBS2, and EBS1d
intron regions corresponding to position 176a of the
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constitutive C. pasteurianum thiolase promoter con-
trolling transcription of the intron and ltrA gene. The
gBlock fragment was PCR-amplified using primers
SYCP.gBlock.S + SYCP.gBlock.AS, digested with BamHI +
BsrGI, and ligated into the corresponding sites of pMut98
to generate pSYCP-cpaAIR. To retarget the ClosTron vec-
tors pMTLCP-E2 and pMTLCP-E6 to the cpaAIR gene of
C. pasteurianum, primers MTLCP.REN-HindIII.S and
SYCP.gBlock.AS were used to amplify the gBlock targeted
to the CpaAI endonuclease. The resulting 384 bp PCR
product was digested with HindIII + BsrGI and ligated into
the corresponding sites of pMTLCP-E2 and pMTLCP-E6
to give pMTLCP-E2-cpaAIR and pMTLCP-E6-cpaAIR,
respectively.
Single molecule real-time genome sequencing and
methylome analysis
SMRT sequencing was performed on intact, purified
genomic DNA from C. pasteurianum according to a
previous report [33]. SMRT reads were assembled by the
Biosciences Division at Oak Ridge National Laboratory
(Oak Ridge, Tennessee, United States) and the resulting
assembly was used as a reference genome for methylome
analysis, which was carried out by Pacific Biosciences
(Menlo Park, California, United States).
Group-II-intron-mediated gene disruption, enrichment,
and screening
To isolate a chromosomal gene disruption mutant, plas-
mid pSYCP-cpaAIR was first electrotransformed into C.
pasteurianum and transformants were selected using
10 μg ml−1 thiamphenicol. Mosaic colonies containing both
wild-type and intron insertion cells were identified with two
separate PCRs using primers ltrB.Fw + REN.Fw for one
chromosome-intron junction and primers ltrB.Rv + REN.Rv
for the adjacent junction. One positive colony was selected
for enrichment of the intron disruption by repeated subcul-
turing in selective growth medium. Briefly, a sporulated col-
ony was heat-shocked in 10 ml of 2 × YTG medium, cooled
on ice, and supplemented with 10 μg ml−1 thiamphenicol
(Sigma-Aldrich; St. Louis, Missouri, United States). Follow-
ing approximately 24 hours of growth, 0.5 ml was used to
inoculate a tube of 10 ml 2 × YTG containing 10 μg ml−1
thiamphenicol. This process was repeated every 12 hours
for a total of 10 transfers, at which time serial dilutions were
plated onto nonselective 2 × YTG agar. To identify a homo-
geneous gene disruption colony, colony PCR was performed
on enrichment colonies using two gene-specific primers
flanking the intron insertion site (REN.Fw +REN.Rv).
Curing ΔcpaAIR cells of plasmid pSYCP-cpaAIR
To cure ΔcpaAIR disruption cells of the pSYCP-cpaAIR
intron donor plasmid, a single ΔcpaAIR disruption colonywas heat-shocked in 10 ml 2 × YTG medium without se-
lection. Once exponential-phase growth was observed,
0.5 ml was used to inoculate a new tube of 10 ml 2 ×
YTG. This process was repeated every 12 hours for a total
of three transfers, at which time serial dilutions were
plated onto nonselective 2 × YTG agar. Colonies were
screened for the absence of plasmid pSYCP-cpaAIR by
restreaking onto both non-selective and selective
(10 μg ml−1 thiamphenicol) 2 × YTG agar plates. For
thiamphenicol-sensitive colonies, plasmid loss was fur-
ther confirmed by lack of colony PCR amplification
using primers Frag3.BglII.S + Frag3.EcoO109I.AS and
absence of growth in liquid 2 × YTG medium containing
10 μg ml−1 thiamphenicol.
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